KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Tenet Healthcare (THC) Accumulated Depreciation & Amortization (2016 - 2025)

Tenet Healthcare (THC) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with $6.7 billion as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 14.99% year-over-year to $6.7 billion; the TTM value through Dec 2025 reached $6.7 billion, up 14.99%, while the annual FY2025 figure was $6.7 billion, 14.99% up from the prior year.
  • Accumulated Depreciation & Amortization hit $6.7 billion in Q4 2025 for Tenet Healthcare, up from $5.8 billion in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $6.7 billion in Q4 2025 and bottomed at $5.8 billion in Q4 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $6.2 billion, with a median of $6.2 billion recorded in 2022.
  • Year-over-year, Accumulated Depreciation & Amortization fell 10.33% in 2024 and then increased 14.99% in 2025.
  • Tenet Healthcare's Accumulated Depreciation & Amortization stood at $6.0 billion in 2021, then increased by 4.04% to $6.2 billion in 2022, then rose by 4.47% to $6.5 billion in 2023, then dropped by 10.33% to $5.8 billion in 2024, then increased by 14.99% to $6.7 billion in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $6.7 billion, $5.8 billion, and $6.5 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.